• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM24 的过表达与非小细胞肺癌的肿瘤进展相关。

Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer.

机构信息

Department of Pathology, the First Affiliated Hospital of China Medical University and Department of Pathology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, China.

出版信息

PLoS One. 2012;7(5):e37657. doi: 10.1371/journal.pone.0037657. Epub 2012 May 30.

DOI:10.1371/journal.pone.0037657
PMID:22666376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3364288/
Abstract

The objective of the current study was to investigate the expression pattern and clinicopathological significance of TRIM24 in patients with non-small cell lung cancer (NSCLC). The expression profile of TRIM24 in NSCLC tissues and adjacent noncancerous lung tissues was detected by immunohistochemistry. TRIM24 was found to be overexpressed in 81 of 113 (71.7%) human lung cancer samples and correlated with p-TNM stage (p = 0.0006), poor differentiation (p = 0.004), Ki67 index (p<0.0001), cyclin D1(p = 0.0096) and p-Rb expression (p = 0.0318). In addition, depleting TRIM24 expression by small interfering RNA inhibited growth and invasion in lung cell lines. Moreover, TRIM24 depletion induced cell cycle arrest at the G1/S boundary and induced apoptosis. Western blotting analysis revealed that knockdown of TRIM24 decreased the protein levels of Cyclin A, Cyclin B, Cyclin D1, cyclin E and p-Rb and increased P27 expression. These results indicate that TRIM24 plays an important role in NSCLC progression.

摘要

本研究旨在探讨 TRIM24 在非小细胞肺癌(NSCLC)患者中的表达模式及其与临床病理特征的关系。采用免疫组织化学法检测 NSCLC 组织及癌旁正常肺组织中 TRIM24 的表达水平。结果发现,在 113 例人类肺癌样本中,TRIM24 在 81 例(71.7%)中呈高表达,且与 p-TNM 分期(p = 0.0006)、低分化(p = 0.004)、Ki67 指数(p<0.0001)、cyclin D1(p = 0.0096)和 p-Rb 表达(p = 0.0318)相关。此外,通过小干扰 RNA 沉默 TRIM24 表达可抑制肺癌细胞系的生长和侵袭。进一步研究发现,TRIM24 敲低可诱导细胞周期阻滞于 G1/S 期,并诱导细胞凋亡。Western blot 分析显示,TRIM24 下调可降低 Cyclin A、Cyclin B、Cyclin D1、cyclin E 和 p-Rb 的蛋白水平,并增加 P27 的表达。这些结果表明,TRIM24 在 NSCLC 的进展中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/f233062faab9/pone.0037657.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/cd1984b0fb5f/pone.0037657.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/6beb9a624686/pone.0037657.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/8a15c08812d6/pone.0037657.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/82e7471bb690/pone.0037657.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/d6dfd727f745/pone.0037657.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/ff6064661a90/pone.0037657.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/f233062faab9/pone.0037657.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/cd1984b0fb5f/pone.0037657.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/6beb9a624686/pone.0037657.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/8a15c08812d6/pone.0037657.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/82e7471bb690/pone.0037657.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/d6dfd727f745/pone.0037657.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/ff6064661a90/pone.0037657.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf8/3364288/f233062faab9/pone.0037657.g007.jpg

相似文献

1
Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer.TRIM24 的过表达与非小细胞肺癌的肿瘤进展相关。
PLoS One. 2012;7(5):e37657. doi: 10.1371/journal.pone.0037657. Epub 2012 May 30.
2
Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.MTA3的过表达与非小细胞肺癌的肿瘤进展相关。
PLoS One. 2013 Jun 19;8(6):e66679. doi: 10.1371/journal.pone.0066679. Print 2013.
3
Downregulation of circEPSTI1 represses the proliferation and invasion of non-small cell lung cancer by inhibiting TRIM24 via miR-1248 upregulation.环状 RNA EPSTI1 通过上调 miR-1248 抑制 TRIM24 抑制非小细胞肺癌的增殖和侵袭。
Biochem Biophys Res Commun. 2020 Sep 10;530(1):348-354. doi: 10.1016/j.bbrc.2020.06.106. Epub 2020 Aug 10.
4
Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma.TRIM24 的过表达与人类肝细胞癌的发生和进展有关。
PLoS One. 2014 Jan 7;9(1):e85462. doi: 10.1371/journal.pone.0085462. eCollection 2014.
5
Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression.JAM-A 在非小细胞肺癌中的过表达与肿瘤进展相关。
PLoS One. 2013 Nov 12;8(11):e79173. doi: 10.1371/journal.pone.0079173. eCollection 2013.
6
Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.CRKL 过表达与非小细胞肺癌不良预后和细胞增殖相关。
Mol Carcinog. 2013 Nov;52(11):890-9. doi: 10.1002/mc.21935. Epub 2012 Jun 29.
7
Overexpression of WDR79 in non-small cell lung cancer is linked to tumour progression.WDR79在非小细胞肺癌中的过表达与肿瘤进展相关。
J Cell Mol Med. 2016 Apr;20(4):698-709. doi: 10.1111/jcmm.12759. Epub 2016 Feb 5.
8
[Mechanism of TRIM24 to Regulate Resistance of Gefitinib in NSCLC cells].[TRIM24调控非小细胞肺癌细胞对吉非替尼耐药性的机制]
Zhongguo Fei Ai Za Zhi. 2016 Jan;19(1):24-9. doi: 10.3779/j.issn.1009-3419.2016.01.03.
9
Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.Sirtuin 7 通过促进 G1/S 期和上皮-间充质转化以及激活 AKT 和 ERK1/2 信号通路促进非小细胞肺癌的进展。
Oncol Rep. 2020 Sep;44(3):959-972. doi: 10.3892/or.2020.7672. Epub 2020 Jul 7.
10
Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.瞬时受体电位香草酸亚型3(TRPV3)的过表达与非小细胞肺癌的肿瘤进展相关。
Int J Mol Sci. 2016 Mar 24;17(4):437. doi: 10.3390/ijms17040437.

引用本文的文献

1
Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24.活性NRF2肺鳞状细胞癌对NRF2和TRIM24的双重易损性
Mol Cancer. 2025 Jul 17;24(1):197. doi: 10.1186/s12943-025-02401-y.
2
TRIM24 regulates chromatin remodeling and calcium dynamics in cardiomyocytes.TRIM24调节心肌细胞中的染色质重塑和钙动力学。
Cell Commun Signal. 2025 Jul 1;23(1):312. doi: 10.1186/s12964-025-02323-8.
3
Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma.TRIM24在硼替佐米耐药套细胞淋巴瘤蛋白酶体-自噬串扰调节中的作用

本文引用的文献

1
Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.转录辅助因子 TRIM24、TRIM28 和 TRIM33 形成调节复合物,抑制小鼠肝细胞癌。
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8212-7. doi: 10.1073/pnas.1101544108. Epub 2011 Apr 29.
2
Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.TRIM24/TIF-1α 基因表达在乳腺癌中的预后意义。
Am J Pathol. 2011 Apr;178(4):1461-9. doi: 10.1016/j.ajpath.2010.12.026.
3
TRIM24 links a non-canonical histone signature to breast cancer.
Cell Death Discov. 2025 Mar 17;11(1):108. doi: 10.1038/s41420-025-02355-6.
4
The tripartite motif-containing 24 is a multifunctional player in human cancer.含三联基序的蛋白24在人类癌症中发挥着多功能作用。
Cell Biosci. 2024 Aug 19;14(1):103. doi: 10.1186/s13578-024-01289-3.
5
Plasma Circulating mRNA Profile for the Non-Invasive Diagnosis of Colorectal Cancer Using NanoString Technologies.利用纳米串技术进行血浆循环mRNA分析用于结直肠癌的无创诊断
Int J Mol Sci. 2024 Mar 5;25(5):3012. doi: 10.3390/ijms25053012.
6
Genome-wide CRISPR-Cas9 screen analyzed by SLIDER identifies network of repressor complexes that regulate TRIM24.通过SLIDER分析的全基因组CRISPR-Cas9筛选鉴定出调控TRIM24的阻遏物复合物网络。
iScience. 2023 Jun 14;26(7):107126. doi: 10.1016/j.isci.2023.107126. eCollection 2023 Jul 21.
7
Targeting bromodomain-containing proteins: research advances of drug discovery.靶向含溴结构域蛋白:药物研发的研究进展
Mol Biomed. 2023 May 5;4(1):13. doi: 10.1186/s43556-023-00127-1.
8
Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours.组蛋白乙酰化相关长链非编码RNA:预测肺腺癌预后和免疫反应以及区分冷热肿瘤的潜在生物标志物
Front Immunol. 2023 Mar 17;14:1139599. doi: 10.3389/fimmu.2023.1139599. eCollection 2023.
9
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape.错综复杂的对抗:TRIM 家族蛋白在肿瘤免疫逃逸中的研究进展与应用潜力。
J Adv Res. 2023 Dec;54:147-179. doi: 10.1016/j.jare.2023.01.011. Epub 2023 Feb 2.
10
Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review.溴结构域家族成员作为癌症干性的调控因子——全面综述。
Int J Mol Sci. 2023 Jan 4;24(2):995. doi: 10.3390/ijms24020995.
TRIM24 将一种非典型的组蛋白特征与乳腺癌联系起来。
Nature. 2010 Dec 16;468(7326):927-32. doi: 10.1038/nature09542.
4
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
5
The function of p27 KIP1 during tumor development.p27 KIP1 在肿瘤发展过程中的作用。
Exp Mol Med. 2009 Nov 30;41(11):765-71. doi: 10.3858/emm.2009.41.11.102.
6
Trim24 targets endogenous p53 for degradation.Trim24将内源性p53作为降解靶点。
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11612-6. doi: 10.1073/pnas.0813177106. Epub 2009 Jun 25.
7
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.人类癌症中的细胞周期蛋白依赖性激酶抑制剂p27:预后潜力及与抗癌治疗的相关性
Nat Rev Cancer. 2008 Apr;8(4):253-67. doi: 10.1038/nrc2347.
8
Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alpha.缺乏TIF1α的小鼠中的动脉钙化及维生素D受体靶点表达增加
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2598-603. doi: 10.1073/pnas.0712030105.
9
Cyclin D1 and breast cancer.细胞周期蛋白D1与乳腺癌
Breast. 2006 Dec;15(6):718-27. doi: 10.1016/j.breast.2006.02.005. Epub 2006 May 3.
10
Cyclin D1: polymorphism, aberrant splicing and cancer risk.细胞周期蛋白D1:多态性、异常剪接与癌症风险。
Oncogene. 2006 Mar 13;25(11):1620-8. doi: 10.1038/sj.onc.1209371.